SetPoint Medical is developing novel bioelectronic medicine therapies to treat those who suffer from autoimmune diseases such as rheumatoid arthritis, Crohn's Disease and multiple sclerosis.  The company has developed a proprietary and innovative bioelectronic medicine platform consisting of a micro-regulator programmed via a unique prescription pad based interface.  This novel therapy has the potential to provide patients and healthcare providers with a safe and efficacious alternative to drugs, while costing payers significantly less than  biologic therapies.

Runway Growth Capital

Action Potential Venture Capital

Euclidean Capital

Boston Scientific

Citta Capital

New Enterprise Associates

Gilmartin Capital LLC

SVE Capital

Richard King Mellon Foundation

Shangbay Capital

CITA Investissement

Midas Capital

Morgenthaler Ventures

Topspin Fund

Revelation Partners

SetPoint Medical

This holiday season, we want to take a moment to extend our gratitude to all the SetPoint employees who worked so hard to make this year special. Your passion and dedication to developing this novel therapy to help RA patients is deeply inspiring! We celebrated this year’s numerous achievements with some great food and holiday cheer.

Wishing each of you and your loved ones a holiday season brimming with joy, peace, and good health.

This #Thanksgiving, we want to extend our profound gratitude to all the incredible people who make the RESET-RA study possible. We deeply appreciate the dedication and hard work of our partners, investigators, and staff. And to our RA study participants, your resilience and strength are truly inspiring. You are appreciated immensely! We look forward to our continued collaboration with you as we evaluate the therapeutic potential of this technology. Wishing our entire community a warm and joyful Thanksgiving!

🧟‍♀️ 🧛‍♂️ #HappyHalloween2023 🧛‍♀️ 🧟‍♂️ 

Each year, we are amazed at the ingenuity and creativity of our team!

#TheSetPointAdvantage

IPhone / Mobile Compatible

Viewport Meta

Google Tag Manager

Apple Mobile Web Clips Icon

Google Analytics

HSTS

Google Maps

WordPress

Content Delivery Network

Global Site Tag

President and Chief Executive Officer

Murthy Simhambhatla

Vice President Regulatory Affairs

Alexis Dineen

Vice President of Marketing

Ankit Shah

Vice President, Clinical Affairs

Anna Gawlicka

Vice President Product Development

Bill Calle

Vice President of Operations

John Long

Vice President of Research

Yaakov Levine

Principal Mechanical Engineer

Brennan Stevenson

Director of Program Management

Dan Ward

Director of Field Medical Affairs, Medical Science Liaisons

Emmett Glass

Allan Will

Josh Makower

Juan-Pablo Mas

Zack Scott

Kevin Tracey

Shaw Warren

William Dai

Michael Weinblatt

Chief Executive Officer

David Chernoff

Rohan Seth

Chief Medical Officer

Gulam Emadi

Principal Systems Engineer

Vice President of Product Development

West Coast Companies With Fewer Than 1000 Employees (Top 10K)

California Therapeutics Companies

Health Care Companies With Less Than $1B in Revenue (Top 10K)

Catalio Capital Management Portfolio Companies

SetPoint Medical is a privately held clinical-stage healthcare company dedicated to treating patients with chronic autoimmune diseases. The company is developing a novel platform designed to stimulate the vagus nerve to activate the inflammatory reflex to produce a systemic immune-restorative effect. SetPoint Medical’s platform technology is designed to offer patients and providers a treatment alternative for rheumatoid arthritis, inflammatory bowel disease and other chronic autoimmune conditions with potentially less risk and cost than drug therapy.

Debt Financing - SetPoint Medical

Norwest Venture Partners

Viking Global Investors

Venture Round - SetPoint Medical

Series D - SetPoint Medical

Series C - SetPoint Medical

Valencia

California

United States

North America

SetPoint Medical has positive data from rechargable neurostim study

SetPoint Medical Announces Positive Topline Results from Landmark RESET-RA Study Evaluating Neuroimmune Modulation for the Treatment of Rheumatoid Arthritis

Setpoint reports results of RA neuroimmune modulation treatment study

Setpoint Gets Breakthrough FDA Rulings

SetPoint Medical Accepted into FDA Total Product Life Cycle Advisory Program for Development of its Neuroimmune ...

SetPoint joins FDA's TAP programme with MS device

FDA adds SetPoint Medical's nerve stim tech to advisory program

SetPoint Medical Receives FDA Breakthrough Device Designation

United Kingdom

Europe

Bangladesh

Asia

Pakistan

HTML5

Lightbox

Modernizr

Wordpress

Google Maps API

Apache Server

DigiCert

Google Fonts

Office 365

SetPoint Medical is pioneering bioelectronic medicine therapies to treat autoimmune diseases such as rheumatoid arthritis, Crohn's Disease, and multiple sclerosis. The company has developed a proprietary bioelectronic medicine platform consisting of a micro-regulator programmed via a unique prescription pad-based interface, offering a safe and efficacious alternative to drugs.

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general	Oct 30, 2024 1:02 PM	dd113970
crunchbase profile	general	Oct 30, 2024 10:28 PM	63d0220c
li profile	general	Feb 1, 2024 2:55 PM	8b37f63d
translate crunchbase fundingrounds	general	Nov 6, 2024 3:12 PM	5c1d7e67
peers	general	Feb 1, 2024 2:55 PM	3a5ea54b
news basic	general
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

COM:SETPOINTMEDICAL

SetPoint Medical